Infectious Disease News, March 2017
To mark our 30th anniversary, Infectious Disease News will be examining some of the infectious diseases that have defined and changed the field over the past 3 decades
At the American Association for the Study of Liver Diseases annual meeting in 2011, Ed Gane, MBChB, MD, FRACP, MNZM, presented data on PS7977, an antiviral agent for the treatment of hepatitis C virus infection. The treatment approach changed slightly across patient groups — some participants were treated for longer than others, and some received PS7977 in combination with ribavirin and pegylated interferon — but the results were always the same.
Continue reading....
Of Interest
Hepatitis C Timeline
This timeline spans from the first recorded references to hepatitis epidemics, to the 1989 discovery of the hepatitis C virus, ending with the FDA approved treatments used today.
At the American Association for the Study of Liver Diseases annual meeting in 2011, Ed Gane, MBChB, MD, FRACP, MNZM, presented data on PS7977, an antiviral agent for the treatment of hepatitis C virus infection. The treatment approach changed slightly across patient groups — some participants were treated for longer than others, and some received PS7977 in combination with ribavirin and pegylated interferon — but the results were always the same.
Continue reading....
Of Interest
Hepatitis C Timeline
This timeline spans from the first recorded references to hepatitis epidemics, to the 1989 discovery of the hepatitis C virus, ending with the FDA approved treatments used today.
No comments:
Post a Comment